1. 43. See, for example, Gillott, supra note 37; and Wilfond, and Fost, supra note 23.
2. “Evaluation of a Tay-Sachs Disease Screening Program,”;Clow;Clinical Genetics,2003
3. 106. Krisher, et al., supra note 101, at 172.
4. 30. Zeesman, et al., supra note 25, at 773.
5. 18. Scriver, and Clow, supra note 17.